The T-body approach: potential for cancer immunotherapy

Overview of attention for article published in Seminars in Immunopathology, June 1996

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 7 patents

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 80 Dimensions

Readers on

mendeley: 59 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 7 patents that reference this research output.

Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor…

Grant US-11325962-B2

United States of America

Redirected, genetically-engineered T regulatory cells and their use in suppression of…

Grant US-11326147-B2

United States of America

Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor…

Grant US-9469684-B2

United States of America

Polypeptides derived from cyclin B1 and uses thereof

Grant US-8748170-B2

United States of America

Anticancer vaccine and diagnostic methods and reagents

Grant US-8211436-B2

United States of America

Anticancer vaccine and diagnostic methods and reagents

Grant US-7704507-B2

United States of America

Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor…

Grant US-7655461-B2

United States of America